Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

693103.pdf (1.2 MB)

Document type

Article

Version

Published version

Publication date

2019-11-12

Publication license

cc-by (c) Souto, Eliana B. et al., 2019
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/145517

Trends in Atopic Dermatitis-From Standard Pharmacotherapy to Novel Drug Delivery Systems

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.3390/ijms20225659

Abstract

Atopic dermatitis (AD) is a predominant and deteriorating chronic inflammation of the skin, categorized by robust burning and eczematous lacerations in diverse portions of the body. AD affects about 20% of both offspring and adults worldwide. The pathophysiology of AD combines environmental, hereditary, and immunological aspects, together with skin barrier dysfunction. The procedures used to prevent the disease are the everyday usage of creams to support the restoration of the epidermal barrier. The classical treatments include the use of topical corticosteroids as a first-line therapy, but also calcineurin inhibitors, antihistamines, antibiotics, phototherapy, and also immunosuppressant drugs in severe cases of AD. Topical drug delivery to deeper skin layers is a difficult task due to the skin anatomic barrier, which limits deeper penetration of drugs. Groundbreaking drug delivery systems, based on nanoparticles (NPs), have received much attention due to their ability to improve solubility, bioavailability, diffusion, targeting to specific types of cells, and limiting the secondary effects of the drugs employed in the treatment of AD. Even so, additional studies are still required to recognize the toxicological characteristics and long-term safety of NPs. This review discusses the current classical pharmacotherapy of AD against new nanoparticle skin delivery systems and their toxicologic risks. KEYWORDS: atopic dermatitis; drug delivery systems; nanoparticles; nanotechnology; pharmacological treatment

Subject

Dermatitis atòpica, Sistemes d'administració de medicaments, Nanopartícules, Nanotecnologia

Subject (English)

Atopic dermatitis, Drug delivery devices, Nanoparticles, Nanotechnology

Citation

Collections

Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)

Citation

SOUTO, Eliana B., et al. Trends in Atopic Dermatitis-From Standard Pharmacotherapy to Novel Drug Delivery Systems. International Journal of Molecular Sciences. 2019. Vol. 20, num. 5659. ISSN 1661-6596. [consulted: 11 of August of 2026]. Available at: https://hdl.handle.net/2445/145517

Export metadata

JSON - METS

Share record